Related Experiment Video
Updated: May 6, 2026
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
Published on: July 28, 2020
Outcome of 1773 superficial non-dermatofibrosarcoma sarcomas A French Sarcoma Group study (FSG) from the NETSARC
Emmanuelle Bompas1, Loic Campion1, Maud Toulmonde2
1Department of Medical Oncology, Institut Cancerologie de l'Ouest, Site René Gauducheau, Saint -Herblain, France.
Background:
Clinical practice guidelines for managing superficial non-dermatofibrosarcoma soft tissue sarcomas (NDSTS) vary depending on surgical margins. This study assessed NDSTS outcomes by margin status and re-excision (RE) in the nationwide NETSARC+ database.
Methods:
This retrospective study (MR004-346) of 1773 patients used clinical data from the NETSARC database between 01/01/2010 and 12/30/2017. Analyses focused on local relapse-free survival (LRFS) and overall survival (OS).
Results:
Pre-surgery, 31 % of patients underwent local staging with imaging, 46 % biopsy, and 17.8 % a reference center multidisciplinary tumor board (MDTB). Initial margin quality was R0, R1, R2, and unknown for 37 %, 36 %, 13 %, and 12.8 % of patients respectively. Univariate analysis positively correlated R0 surgery with preoperative biopsy (p < 0.001), adequate local imaging for tumors ≥ 5 cm (p < 0.009), case discussion within a NETSARC+ MDTB (p < 0.001), and tumor size< 5 cm (p < 0.001). Reference network surgery resulted in higher proportions of R0 margins (p < 0.001). Re-excision (RE) was performed in 9.7 %, 63 %,79 %, and 34 % of patients following initial surgery with R0, R1, R2, and unknown margins, respectively. Multivariate analysis identified several poor LRFS prognostic factors: size ≥ 5 cm (HR=1.47, p = 0.002), angiosarcoma (HR=2.95, p < 0.001), surgery outside a NETSARC network (HR=1.61, p = 0.003), old age (p < 0.001), and no final R0 margin (HR=2.60, p < 0.001). Multivariate analysis identified several poor OS prognostic factors: angiosarcoma (HR=2.03, p = 0.065), trunk/head and neck site (HR=1.57, p = 0.004), grades 2 and 3 (respectively HR=2.21, p = 0.039 and HR=4.35, p < 0.001), age (p < 0.001), and no final R0 margins (HR=2.02, p < 0.001).
Conclusion:
Sarcoma clinical practice guideline compliance was associated with better surgery quality, reduced local relapse rates, and improved survival.
